Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

We observe an increasing trend in risk scores from healthy controls to non-invasive groups and finally to invasive groups, suggesting that the SMART platform may be applicable in pre-screening scenarios.

also in 63,971 other papers